Proteomics and metabolomics in cancer drug development.
D'Alessandro, Angelo
Proteomics and metabolomics in cancer drug development. [electronic resource] - Expert review of proteomics Oct 2013 - 473-88 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1744-8387
10.1586/14789450.2013.840440 doi
Animals
Antineoplastic Agents--therapeutic use
Apoptosis--genetics
Autophagy
Drug Discovery
Genetic Therapy--methods
Glycoproteins--metabolism
Humans
Metabolome
Neoplasms--metabolism
Oxidation-Reduction
Peptide Fragments--genetics
Phosphoproteins--metabolism
Proteome--analysis
Tumor Suppressor Protein p53--genetics
Proteomics and metabolomics in cancer drug development. [electronic resource] - Expert review of proteomics Oct 2013 - 473-88 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1744-8387
10.1586/14789450.2013.840440 doi
Animals
Antineoplastic Agents--therapeutic use
Apoptosis--genetics
Autophagy
Drug Discovery
Genetic Therapy--methods
Glycoproteins--metabolism
Humans
Metabolome
Neoplasms--metabolism
Oxidation-Reduction
Peptide Fragments--genetics
Phosphoproteins--metabolism
Proteome--analysis
Tumor Suppressor Protein p53--genetics